Iterum UTI Therapy OKd

 ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades

--Company to Host Conference Call on Monday, October 28th at 8:30 a.m. EDT--

Iterum will host a conference call on Monday, October 28, 2024, at 8:30 a.m. Eastern Time. The dial-in information for the call is as follows:

United States: 1 833 470 1428 / International: 1 404 975 4839

Access code: 936149  

The conference call replay will be available in the Events & Presentations section of Iterum’s website following the call.

https://www.globenewswire.com/news-release/2024/10/25/2969543/0/en/Iterum-Therapeutics-Receives-U-S-FDA-Approval-of-ORLYNVAH-Oral-Sulopenem-for-the-Treatment-of-Uncomplicated-Urinary-Tract-Infections.html